Inventor · disambiguated record
Wei Zhu
Also filed as: ZHU WEI · Zhu wei-zhong
63 granted patents·61 pending applications·181 citations·filing 2003–2025
98Inventor score
Files withHOFFMANN LA ROCHE54GENEHEAL BIOTECHNOLOGY CO LTD7TUOJIE BIOTECH SHANGHAI CO LTD4UNIV NEW YORK STATE RES FOUND4CELLULAR BIOMEDICINE GROUP INC3
Top patents by PatentIndex Score
124 records- 0196US11472858B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2021·Granted Oct 18, 2022·7 cites·4 claims
- 0295US11618778B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 4, 2023·7 cites·6 claims
- 0395US11608369B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Mar 21, 2023·7 cites·6 claims
- 0495US9181625B2Devices and processes for carbon dioxide conversion into useful fuels and chemicalsDioxide Materials Inc·Filed 2013·Granted Nov 10, 2015·23 cites·25 claims
- 0594US11066457B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP HK LTD·Filed 2018·Granted Jul 20, 2021·8 cites·8 claims
- 0694US9447086B26-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2013·Granted Sep 20, 2016·34 cites·5 claims
- 0793US9233978B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 12, 2016·18 cites·23 claims
- 0891US9597333B2Benzazepine dicarboxamide compoundsHOFFMANN LA ROCHE·Filed 2016·Granted Mar 21, 2017·10 cites·17 claims
- 0990US10081627B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Sep 25, 2018·9 cites·30 claims
- 1089US10428069B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2018·Granted Oct 1, 2019·6 cites·21 claims
- 1188US8815593B2Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signalingUNIV WASHINGTON·Filed 2013·Granted Aug 26, 2014·5 cites·18 claims
- 1287US11007198B2ErbB/BTK inhibitorsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted May 18, 2021·2 cites·5 claims
- 1387US9822065B1Benzazepine dicarboxamide compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Nov 21, 2017·5 cites·5 claims
- 1487US9475775B2Benzazepine dicarboxamide compoundsHOFFMANN LA ROCHE·Filed 2016·Granted Oct 25, 2016·6 cites·19 claims
- 1584US10857260B2Coaxial needle for fabricating a multi scale, multi layer blood vessel or vascular network employing 3D bioprintingUNIV GEORGE WASHINGTON·Filed 2018·Granted Dec 8, 2020·3 cites·23 claims
- 1684US9890124B2Benzazepine sulfonamide compoundsHOFFMANN LA ROCHE·Filed 2017·Granted Feb 13, 2018·5 cites·20 claims
- 1782US11504375B2ErbB/BTK inhibitorsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2021·Granted Nov 22, 2022·1 cites·23 claims
- 1882US11041011B2Human alpha fetoprotein-specific murine T cell receptors and uses thereofUNIV RES INST INC AUGUSTA·Filed 2018·Granted Jun 22, 2021·1 cites·3 claims
- 1981US2023242613A1Construction of chimeric antigen receptor targeting cd20 antigen and activity identification of engineered t cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 2080US9266904B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2014·Granted Feb 23, 2016·5 cites·23 claims
- 2179US9758530B26-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2016·Granted Sep 12, 2017·3 cites·14 claims
- 2276US8865696B2Morphine and morphine precursorsUNIV NEW YORK STATE RES FOUND·Filed 2013·Granted Oct 21, 2014·2 cites·16 claims
- 2376US8481559B2Morphine and morphine precursorsSTEFANO GEORGE B·Filed 2010·Granted Jul 9, 2013·4 cites·17 claims
- 2475US12247036B2Tricyclic compounds for the treatment of cancerHOFFMANN LA ROCHE·Filed 2024·Granted Mar 11, 2025·0 cites·27 claims
- 2575US11713327B2Heteroaryl heterocyclyl compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2019·Granted Aug 1, 2023·1 cites·17 claims
- 2674US12351575B26-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2019·Granted Jul 8, 2025·0 cites·13 claims
- 2774US10688223B2Smart release system for growth factor delivery and combined bone and vascular growthTHE GEORGE WASHINGTON UNIV A CONGRESSIONALLY CHARTERED NOT FOR PROFIT CORPORATION·Filed 2017·Granted Jun 23, 2020·3 cites·8 claims
- 2872US10709676B2Applications of spermine and derivatives thereofGENEHEAL BIOTECHNOLOGY CO LTD·Filed 2017·Granted Jul 14, 2020·1 cites·13 claims
- 2968US12173045B2Human alpha fetoprotein-specific t cell receptors and uses thereofUNIV RES INST INC AUGUSTA·Filed 2021·Granted Dec 24, 2024·0 cites·5 claims
- 3068US2025257075A1Macrocyclic inhibitors of kras for the treatment of cancerHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3167US12492164B2Fluorine substituted cyclohexene analogues of gamma-aminobutyric acid (GABA)UNIV NORTHWESTERN·Filed 2020·Granted Dec 9, 2025·0 cites·24 claims
- 3266US11261222B2Transdermal peptide with nuclear localization ability and use thereofUNIV SOOCHOW·Filed 2020·Granted Mar 1, 2022·0 cites·4 claims
- 3366US2024360126A1Pyrazolo[3,4-b]pyridine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3464US12103915B2TEAD inhibitors and methods of uses thereofINSILICO MEDICINE IP LTD·Filed 2023·Granted Oct 1, 2024·0 cites·26 claims
- 3564US9474749B2Morphine and morphine precursorsUNIV NEW YORK STATE RES FOUND·Filed 2014·Granted Oct 25, 2016·0 cites·15 claims
- 3664US8603817B2Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signalingLAFLAMME MICHAEL A·Filed 2009·Granted Dec 10, 2013·0 cites·8 claims
- 3764US7959951B2Nitric oxide and its biomedical significanceRES FOUNDATION AT STATE UNIVERSITY OF NEW YORK·Filed 2003·Granted Jun 14, 2011·5 cites·13 claims
- 3864US2025340569A1Inhibitors of kif18a and uses thereofINSILICO MEDICINE IP LTD·Filed 2025·Application pending·0 cites
- 3964US2025171397A1(3s,4r)-3-amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic acid and related compounds as selective inactivators of ornithine aminotransferaseUNIV NORTHWESTERN·Filed 2023·Application pending·0 cites
- 4063US11046671B2Dihydropyrimidinyl benzazepine carboxamide compoundsHOFFMANN LA ROCHE·Filed 2020·Granted Jun 29, 2021·0 cites·18 claims
- 4163US2025206761A1Haloindole macrocyclic compounds for the treatment of cancerHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 4262US2014329311A1Induction of human embryonic stem cell derived cardiac pacemaker or chamber-type cardiomyocytes by manipulation of neuregulin signalingUNIV WASHINGTON·Filed 2014·Application pending·0 cites
- 4361US2014128420A1Nutritional supplement compositionsUNIV NEW YORK STATE RES FOUND·Filed 2014·Application pending·0 cites
- 4460US10858408B2Transdermal peptide with nuclear localization ability and use thereofUNIV SOOCHOW·Filed 2017·Granted Dec 8, 2020·0 cites·4 claims
- 4560US2024408088A1Pyrazole derivative, and preparation method therefor and use thereof in medicineABBISKO THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 4659US2025376482A1Tricyclic compounds for the treatment of cancerHOFFMANN LA ROCHE·Filed 2025·Application pending·0 cites
- 4759US2020297660A1Applications of spermine and derivatives thereofGENEHEAL BIOTECHNOLOGY CO LTD·Filed 2020·Application pending·0 cites
- 4858US10590112B2Dihydropyrimidinyl benzazepine carboxamide compoundsHOFFMANN LA ROCHE·Filed 2018·Granted Mar 17, 2020·0 cites·14 claims
- 4957US12503471B2Triazatricycle compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 23, 2025·0 cites·15 claims
- 5057US12486273B2Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseaseHOFFMANN LA ROCHE·Filed 2020·Granted Dec 2, 2025·0 cites·18 claims
Showing the top 50 of 124 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Wei Zhu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →